Balchem's (BCPC) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright restated their buy rating on shares of Balchem (NASDAQ:BCPC - Free Report) in a report released on Monday morning,Benzinga reports. They currently have a $190.00 price objective on the basic materials company's stock. HC Wainwright also issued estimates for Balchem's Q1 2025 earnings at $0.99 EPS, Q2 2025 earnings at $1.03 EPS, Q3 2025 earnings at $1.08 EPS, Q4 2025 earnings at $1.12 EPS, FY2025 earnings at $4.22 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.17 EPS, Q3 2026 earnings at $1.20 EPS, Q4 2026 earnings at $1.22 EPS and FY2026 earnings at $4.71 EPS.

Separately, StockNews.com raised Balchem from a "hold" rating to a "buy" rating in a report on Monday, October 28th.

Balchem Stock Down 0.4 %

NASDAQ:BCPC traded down $0.69 during midday trading on Monday, hitting $172.00. 150,889 shares of the company were exchanged, compared to its average volume of 131,671. Balchem has a fifty-two week low of $137.69 and a fifty-two week high of $186.03. The company has a market capitalization of $5.59 billion, a PE ratio of 43.77, a price-to-earnings-growth ratio of 4.41 and a beta of 0.69. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. The company has a fifty day simple moving average of $162.24 and a 200 day simple moving average of $169.48.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The firm had revenue of $240.00 million for the quarter, compared to analyst estimates of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. As a group, equities analysts anticipate that Balchem will post 4.64 earnings per share for the current fiscal year.

Balchem Increases Dividend

The firm also recently announced an annual dividend, which was paid on Friday, January 17th. Stockholders of record on Thursday, December 26th were paid a dividend of $0.87 per share. This is an increase from Balchem's previous annual dividend of $0.79. The ex-dividend date of this dividend was Thursday, December 26th. This represents a dividend yield of 0.4%. Balchem's dividend payout ratio is 22.14%.

Hedge Funds Weigh In On Balchem

Several institutional investors have recently added to or reduced their stakes in BCPC. Watts Gwilliam & Co. LLC grew its stake in shares of Balchem by 63.7% in the 4th quarter. Watts Gwilliam & Co. LLC now owns 35,069 shares of the basic materials company's stock valued at $5,438,000 after purchasing an additional 13,642 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Balchem by 1.7% during the third quarter. JPMorgan Chase & Co. now owns 458,986 shares of the basic materials company's stock worth $80,782,000 after purchasing an additional 7,721 shares during the period. Stifel Financial Corp grew its position in Balchem by 26.2% in the 3rd quarter. Stifel Financial Corp now owns 11,893 shares of the basic materials company's stock valued at $2,093,000 after buying an additional 2,467 shares during the last quarter. Apollon Wealth Management LLC purchased a new position in Balchem in the 4th quarter valued at $503,000. Finally, Congress Asset Management Co. increased its stake in Balchem by 5.4% in the 4th quarter. Congress Asset Management Co. now owns 317,610 shares of the basic materials company's stock valued at $51,769,000 after buying an additional 16,170 shares during the period. Institutional investors and hedge funds own 87.91% of the company's stock.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.